Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019866 |
---|---|
Receipt number | R000022948 |
Scientific Title | Phase I/II study on the safety and pharmacokinetics of FIT039 administered by single adhesive skin patch application for the cases of human papillomavirus verrucae |
Date of disclosure of the study information | 2016/03/31 |
Last modified on | 2020/08/18 13:52:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/19 22:53:33 | ||
2 | Update | 2016/04/08 09:21:29 | Name of primary person or sponsor Organization Category of Funding Organization |
|
3 | Update | 2016/04/12 17:49:19 | Primary outcomes Primary outcomes |
|
4 | Update | 2017/05/11 12:54:25 | Recruitment status Last follow-up date Date of closure to data entry Results |
|
5 | Update | 2020/08/13 23:51:35 | 1st name of lead principal investigator Middle name of lead principal investigator 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Department Division Nationality of Funding Organization Nationality of Funding Organization Organization Organization Address Address Tel |
|
6 | Update | 2020/08/14 00:13:16 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
7 | Update | 2020/08/14 00:15:17 | Date of IRB Date trial data considered complete Date analysis concluded |
|
8 | Update | 2020/08/18 13:49:40 | Results Adverse events Adverse events |
|
9 | Update | 2020/08/18 13:52:54 | Date of IRB Anticipated trial start date Date trial data considered complete Date analysis concluded |